Business Description
Voyageur Pharmaceuticals Ltd
NAICS : 325412
SIC : 3741
ISIN : CA92916K1057
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 11.7 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | -26 | |||||
3-Year Book Growth Rate | 40.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.73 | |||||
9-Day RSI | 49.86 | |||||
14-Day RSI | 49.77 | |||||
6-1 Month Momentum % | 27.27 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23 | |||||
Shareholder Yield % | -5.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -110.84 | |||||
ROA % | -66.26 | |||||
ROIC % | -69.63 | |||||
ROC (Joel Greenblatt) % | -72.42 | |||||
ROCE % | -106.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 9.28 | |||||
Price-to-Tangible-Book | 6.5 | |||||
EV-to-EBIT | -5.97 | |||||
EV-to-EBITDA | -5.97 | |||||
EV-to-FCF | -27.01 | |||||
Earnings Yield (Greenblatt) % | -16.79 | |||||
FCF Yield % | -3.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Voyageur Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.009 | ||
Beta | 0.04 | ||
Volatility % | 106.99 | ||
14-Day RSI | 49.77 | ||
14-Day ATR (C$) | 0.004166 | ||
20-Day SMA (C$) | 0.0655 | ||
12-1 Month Momentum % | 100 | ||
52-Week Range (C$) | 0.035 - 0.09 | ||
Shares Outstanding (Mil) | 139.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Voyageur Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Voyageur Pharmaceuticals Ltd Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Voyageur Pharmaceuticals Ltd Frequently Asked Questions
What is Voyageur Pharmaceuticals Ltd(TSXV:VM)'s stock price today?
When is next earnings date of Voyageur Pharmaceuticals Ltd(TSXV:VM)?
Does Voyageur Pharmaceuticals Ltd(TSXV:VM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |